Bulls Need a Big Day, or Else

George Brooks |

Wall Street Bull StocksBrooksie's Daily Stock Market blog  -  an edge before the open

Friday, September 30, 2011    9: 17 am EDT

DJIA: 11,153.98     S&P 500: 1160.40

TODAY: Yesterday’s strength was solely due to better-than-expected Jobless Claims and Q2 GDP data.

Early trading today should produce a loss of  100 points in the DJIA.  The market has been locked in a wide trading range (consolidation) since August 9. Bulls need to blow it out above  DJIA 11,740 (S&P 500: 1220). Bears gain control on a break below DJIA 10,572 (S&P 500: 1101).

The September Chicago ISM report, due out at 9:45 is expected to drop to 55 from 56.5 in August. A reflection of manufacturing and non-manufacturing activity in the Chicago region, it has been down five out of  the last six  months. We need a surprise here, i.e., up, not down.

While U.S. economic indicators are not indicating a rush to recession, they are borderline, at best.  The risk of a European recession is gaining traction.  A Bloomberg News survey indicates that two-thirds of international investors  believe the economy is deteriorating, up from 18% in May. The delay in arriving at a meaningful solution to the euro-zone debt crisis is a big contributor to this sagging sentiment which undoubtedly  is contributing to a softness in their economies.

It’s important that I repeat yesterday’s “On a more positive note,” since I am looking for an October upturn, but most likely from lower levels.

We are more than two years into the official business expansion, unimpressive as it has been. Expect more of the same, but BEWARE !   At some point,  the BIG money will look out and see something the average investor can’t see - an economy that is beginning to gain traction.  The BIG money will begin to buy aggressively, even pay up for targeted stocks.

At that point, the market will run, and investors will wonder what is happening.  After all, aren’t there a lot of negatives out there ??

12-member SuperCommittee timeline:*

Oct. 1- Dec. 31: Both houses of Congress must vote on a Balanced Budget Amendment.

Oct.: 14: Deadline for House and Senate  Standing Committees to submit recommendations.

Nov. 23: Deadline for both houses to vote on a plan with a 10-year deficit reduction  goal of $1.5 trillion Dec. 2: Deadline for committee to submit report and legislative language to President Obama and

Congress.

Dec. 23: Deadline for both houses to vote on committee bill.

Jan. 15, 2012: Date that the “trigger” leading to $1.2 trillion of future spending cuts goes into effect if

the committee’s legislation has not been enacted.

Feb. 2012: Approximate time when first $900 bn of debt ceiling runs out.

Feb./Mar.2012: Deadline for Congress to consider a resolution of disapproval for the second tranche

($1.2 – $1.5 trillion) of debt limit increase.

Fall/Winter 2012: When additional $2.1 - $2.4 trillion of borrowing authority from this law runs out.

Jan.2, 2013: OMB orders sequestrations for defense and non-defense categories of spending necessary

to meet spending cuts required by the “trigger.”

George  Brooks

*National Journal

…………………………………………………………………………………………………………

The writer of Brooksie’s Daily Stock Market blog, George Brooks,  is not registered as an investment advisor.  Ideas expressed herein are the opinions of the writer, are for informational purposes, and are not to serve as the sole basis for any investment decision. Readers are expected to assume full responsibility for conducting their own research pursuant to investment decisions in keeping with their tolerance for risk.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
DOF.UN:CA First Asset Canadian Dividend Opportunity Fund Uni n/a n/a n/a 0

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…